SACCANI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 1.971
AS - Asia 1.456
EU - Europa 1.400
SA - Sud America 197
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 6
Totale 5.099
Nazione #
US - Stati Uniti d'America 1.922
CN - Cina 583
SG - Singapore 546
FI - Finlandia 345
SE - Svezia 286
IE - Irlanda 236
BR - Brasile 161
DE - Germania 129
IT - Italia 116
HK - Hong Kong 109
VN - Vietnam 81
UA - Ucraina 74
TR - Turchia 57
NL - Olanda 45
GB - Regno Unito 42
ZA - Sudafrica 40
CA - Canada 35
AT - Austria 33
IN - India 29
FR - Francia 21
AR - Argentina 16
BE - Belgio 16
CI - Costa d'Avorio 15
BD - Bangladesh 14
RU - Federazione Russa 13
CZ - Repubblica Ceca 12
MX - Messico 10
EC - Ecuador 9
ES - Italia 9
JP - Giappone 9
LT - Lituania 7
ID - Indonesia 6
PL - Polonia 6
EU - Europa 5
IQ - Iraq 5
MA - Marocco 5
CO - Colombia 3
EG - Egitto 3
KE - Kenya 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
LB - Libano 2
PE - Perù 2
PY - Paraguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GY - Guiana 1
JO - Giordania 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.099
Città #
Singapore 308
Chandler 277
Ashburn 265
Dublin 236
Beijing 154
Santa Clara 129
Dallas 128
Hong Kong 109
Jacksonville 100
Dearborn 96
Boardman 85
Parma 81
New York 74
Nanjing 65
Shanghai 62
Munich 53
Ann Arbor 48
Izmir 44
Princeton 39
Johannesburg 37
Los Angeles 30
Ho Chi Minh City 29
Vienna 29
Helsinki 24
Wilmington 24
Nanchang 23
San Mateo 23
Buffalo 21
Kunming 20
Hebei 19
Hanoi 17
Jinan 17
Bremen 16
Brussels 16
Seattle 16
Toronto 16
Abidjan 15
Des Moines 15
Guangzhou 14
Hefei 14
São Paulo 14
London 12
Pune 11
Shenyang 11
Brooklyn 10
Montreal 10
Tianjin 10
Turku 10
Brno 9
Changsha 9
Denver 9
Houston 9
Tokyo 9
Zhengzhou 9
Hangzhou 8
Jiaxing 8
Norwalk 8
Poplar 8
Stockholm 8
Ottawa 7
Rio de Janeiro 7
Bắc Ninh 6
Chennai 6
New Delhi 6
Phoenix 6
Warsaw 6
Ankara 5
Atlanta 5
Boston 5
Chicago 5
Columbus 5
Dhaka 5
Manchester 5
Marseille 5
Moscow 5
Augusta 4
Cagliari 4
Chengdu 4
Council Bluffs 4
Fremont 4
Quito 4
Redondo Beach 4
Woodbridge 4
Brasília 3
Chongqing 3
Erbil 3
Frankfurt am Main 3
Fuzhou 3
Genoa 3
Grafing 3
Haiphong 3
Jakarta 3
Kocaeli 3
Lanzhou 3
Mantova 3
Milan 3
Nuremberg 3
Olomouc 3
Orem 3
Porto Alegre 3
Totale 3.142
Nome #
Targeting PI3K somatic mutations reduces invasion and EMT in squamous cell carcinoma of the lung 166
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 163
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 160
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 159
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 159
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 156
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 154
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 152
Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations 150
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification 149
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 149
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 147
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 147
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 143
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 143
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines 142
Erlotinib enhances antibody-dependent cellular cytotoxicity of wil-type erlotinib-sensitive NSCLC cell lines 141
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 140
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 134
Analgesic activity of new hybrid muscarinic agonists in mice 134
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 134
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 133
Effects of FGFR1 inhibition on survival, proliferation, and energy metabolism in Non Small Cell Lung Cancer (NSCLC) cell lines 133
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 131
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 130
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 127
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 127
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 125
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 122
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 121
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 119
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 117
Pharmacological modulation of 5HT1A receptors in mice mesenteric ischemia/reperfusion injury: protective effect of Buspirone and WAY100135 107
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 98
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 98
T-DM1: a new therapeutic approach in HER-2 overexpressing NSCLC cell lines 88
Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice. 87
Investigation into the μ opioid receptor role in an experimental model of mesenteric ischemia/reperfusion 82
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 75
Totale 5.142
Categoria #
all - tutte 16.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021105 0 0 0 0 0 2 20 0 36 14 33 0
2021/2022174 2 0 0 25 6 3 23 21 8 10 9 67
2022/2023984 119 132 62 85 81 113 24 38 271 2 46 11
2023/2024337 15 18 4 12 24 92 32 40 18 6 25 51
2024/2025923 26 45 52 64 102 102 32 31 120 75 85 189
2025/20261.368 278 175 209 251 315 140 0 0 0 0 0 0
Totale 5.142